Search clinical trials for: histamine dihydrochloride and IL-2

Total 21674 results

Cytovia, Inc.
EpiCept Corporation

Completed

Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia

Acute Myeloid Leukemia

Sweden
Sahlgrenska University Hospital, Sweden

Not yet recruiting

Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer (PANCEP-1)

Pancreatic Cancer | Surgery | Metastasis | Immunosuppression
Brigham and Women's Hospital

Terminated

Novel Strategies to Improve Immunomodulation and Non-invasive Clinical Monitoring in VCA

Abdominal Wall Defect | Amputation, Traumatic | Amputation;Traumatic;Old | Face Injury | Face; Deformity

United States
Peking University People's Hospital

Unknown

The Incidence of Infection in Treatment of Low-dose IL-2 of SLE Patients

Infection

China
Groupe Francophone des Myelodysplasies
EpiCept Corporation

Withdrawn

Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes

France
Peking University Third Hospital

Recruiting

Low Dose IL-2 in the Treatment of Immune-associated ALS Syndrome

Amyotrophic Lateral Sclerosis

China
University of Minnesota

Completed

Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2

HIV

United States
jiangjingting

Unknown

Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma

Lymphoma, B Cell

China
University of Chicago

Terminated

Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
National Cancer Institute (NCI)

Completed

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

Melanoma | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Terminated

Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

Sarcoma | Breast Neoplasm | Lung Neoplasm | Kidney Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

Non Hodgkin's Lymphoma | Hodgkin's Disease

United States
Oxford BioMedica
The Methodist Hospital Research Institute; ORION Clinical Services

Completed

Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma

Carcinoma, Renal Cell

United States
Iovance Biotherapeutics, Inc.

Active, not recruiting

Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Assistance Publique - Hôpitaux de Paris
Iltoo Pharma

Completed

Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers (HEALTHIL-2)

Healthy Volunteers

France
National Cancer Institute (NCI)

Completed

A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

Rhabdomyosarcoma | Ewing's Sarcoma

United States
Iltoo Pharma

Completed

ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) (LUPIL-2)

Systemic Lupus Erythematosus

France, Spain, Mexico, Austria, Germany, Bulgaria, Italy, Mauritius, Portugal, Romania
Vical

Completed

A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma

Metastatic Melanoma

United States
National Polytechnic Institute, Mexico
Instituto de Oftalmología Fundación Conde de Valenciana

Completed

Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts

Allergic Rhinoconjunctivitis
OncBioMune Pharmaceuticals
United States Department of Defense

Unknown

Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients (PSA)

Prostate Cancer

United States
Jeffrey Bluestone
Yale University

Completed

T1DM Immunotherapy Using Polyclonal Tregs + IL-2 (TILT)

Type 1 Diabetes Mellitus

United States
Belarusian Research Center for Pediatric Oncology...

Completed

Safety of Expanded Haploidentical Natural Killer Cells for Leukemia

Leukemia, Acute Lymphoblastic | Leukemia, Acute Myeloid

Belarus
UCB Pharma

Completed

Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR

Rhinitis, Allergic, Seasonal
BioNTech US Inc.

Recruiting

NEO-PTC-01 in Patients With Advanced or Metastatic Melanoma

Metastatic Melanoma | Unresectable Melanoma

Belgium, Netherlands, Spain
Galderma R&D

Completed

Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

Basal Cell Carcinoma

Australia
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Unknown

A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
UCB Pharma

Completed

Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children

Cough
UCB Pharma

Completed

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

Rhinitis | Allergic | Perennial
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition

Fed

India
Fuzhou General Hospital

Unknown

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma

Renal Cell Carcinoma

China
University Hospital, Limoges

Withdrawn

Treatment of Steroid Dependent Idiopathic Nephrotic Syndrome in Children With Low Doses of Interleukin 2: a Pilot Study (NIL-2 pilote)

Nephrotic Syndrome Steroid-Dependent | Interleukin 2
Oslo University Hospital

Completed

Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma

Malignant Melanoma
Aalborg University Hospital
Aalborg University

Enrolling by invitation

Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes (HistaHeat)

Diabetes | Diabetes Mellitus, Type 1 | Diabetic Neuropathy Peripheral | Small Fiber Neuropathy

Denmark
Instituto Nacional de Enfermedades Respiratorias

Completed

Renal Biomarkers in AKI and COVID-19

Coronavirus Infection | Covid19 | AKI | SARS (Severe Acute Respiratory Syndrome)

Mexico
Dartmouth-Hitchcock Medical Center

Completed

Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

Leukemia | Multiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's Disease | Other Plasma Cell Dyscrasia (Waldenstrom, Amyloidosis)

United States
Bridgette Jones
National Institutes of Health (NIH)

Recruiting

A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3) (HAS3)

Allergic Asthma

United States
Derm Research, PLLC
UCB Pharma

Completed

Management of Pruritus With Xyzal in Atopic Dermatitis

Pruritus | Atopic Dermatitis

United States
Gregory Daniels

Recruiting

High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma

Melanoma Stage Iv | Renal Cell Carcinoma, Metastatic

United States
UCB Pharma

Completed

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition

Fasting State

India
UCB Pharma

Completed

Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects

Rhinitis, Allergic, Seasonal
UCB Pharma

Completed

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Mansoura University

Completed

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

Bladder Cancer

Egypt
HeJing

Completed

Low-dose IL-2 Treatment on Behcet's Disease

Behcet's Disease

China
UCB Pharma

Completed

To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

Rhinitis | Allergic | Seasonal
UCB Pharma

Completed

Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis

Rhinitis | Allergic | Perennial
Maxim Pharmaceuticals

Completed

Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia

Leukemia

United States, France, Israel, Australia, Canada, Sweden, Finland, Germany, New Zealand, Denmark, Estonia, United Kingdom
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells (PRIMAL)

Chronic Lymphocytic Leukemia (CLL)

United States
UCB Pharma

Completed

Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria

Urticaria
PHARMENTERPRISES LLC

Completed

XC8 in the Treatment of Patients With Acute Respiratory Viral Infection

Influenza | Acute Respiratory Infection

Russian Federation

3

Subscribe